Go to deals
Healthcare

Open Orphan has successfully raised capital in an oversubscribed fundraise

Open Orphan Plc has completed an equity placing to raise US$15.5 million to maximize available COVID-19 opportunities and testing.

Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses: hVIVO and Venn Life Sciences, and has offices in London, Dublin, Paris and the Netherlands. The company is led by a management team with deep industry and financial experience.

Oaklins Cavendish’s sister firm finnCap, based in the UK, advised Open Orphan Plc on its oversubscribed equity fundraising of US$15.5 million.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Geoff  Nash

Geoff Nash

Partner

London, United Kingdom
Oaklins Cavendish

Related deals

Spring has completed an equity raise
Real Estate

Spring has completed an equity raise

The owners and management of Spring have completed a fundraising to support its growth strategy.

Learn more
CML Group (ASX:CGR) has completed a placement
Financial Services

CML Group (ASX:CGR) has completed a placement

CML Group (ASX:CGR) has completed a US$2.5 million placement. The raise was completed at an issue price of US$0.238 (A$0.328) per share to institutional and professional investors. Funds raised will be used to support the company’s cash position to fund growth in its loan book.

Learn more
GBM Resources (ASX:GBZ) has successfully raised US$4.6 million
Other Industries

GBM Resources (ASX:GBZ) has successfully raised US$4.6 million

GBM Resources Ltd. (ASX:GBZ) has completed a fundraising to accelerate development.

Learn more